The mTOR/p70S6K Signal Transduction Pathway Plays a Role in Cardiac Hypertrophy and Influences Expression of Myosin Heavy Chain Genes in vivo

Author： Boluyt Marvin O.   Li Zhao Bo   Loyd Amy M.   Scalia Antony F.   Cirrincione Georgina M.   Jackson Rebecca R.  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.18, Iss.4, 2004-07, pp. : 257-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: PI3K/AKT and mTOR/p70S6K1 Signaling Pathways in Human Cancer)

By  

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 233-233

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3K/AKT/mTOR-Signal Transduction Pathway as Drug Target in Triple-Negative Breast Cancer

By  

Clinical Cancer Drugs, Vol. 4, Iss. 1, 2017-05 ,pp. : 47-58

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of triiodo-thyronine on angiotensin-induced cardiomyocyte hypertrophy: reversal of increased β-myosin heavy chain gene expression

By Wang Baohua   Ouyang Jingping   Xia Zhengyuan  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 8-9, 2006-08 ,pp. : 935-941

NRC Research Press

Access to resources Recommend Favorite

mTOR inhibition in breast cancer: unraveling the complex mechanisms of mTOR signal transduction and its clinical implications in therapy

By O'Regan Ruth   Hawk Natalyn Nicole  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 859-872

Informa Healthcare

Access to resources Recommend Favorite

The Role of Hesperidin in Cell Signal Transduction Pathway for the Prevention or Treatment of Cancer

By  

Current Medicinal Chemistry, Vol. 22, Iss. 30, 2015-01 ,pp. : 3462-3471

Bentham Science Publishers

Access to resources Recommend Favorite